3 Nuclear Medicine & Radiation Therapy · • Nuclear Medicine • Radiation Therapy • Medical Imaging • Radiation Physics • Radiation Oncology • Diagnostic Radiology •

conferenceseries.com

http://nuclearmedicine.conferenceseries.com/

Nuclear Medicine 2018

***For available speaker slots***[email protected]

Tentative ProgramNuclear Medicine & Radiation Therapy

March 26-27,2018 | Edinburgh, Scotland

InteractiveSessions

KeynoteLectures

Exhibitors B2BMeetings

PlenaryLectures Workshops

3rd International Conference on

Nuclear Medicine 2018conferenceseries.com


Program at a Glance

Session 1 Session 2

Morning

Session

s

29 Spe

akers for Day 1

General SessionInaugural Address

Keynote Session

Keynote/Plenary Talk 1 (Slot Available)

2nd International Conference & Expo on

Optometry and Vision ScienceSeptember 11-12, 2017 Paris, France

Program at a GlanceDay 1


Lunch Break 6 Speakers (20 min) slot avilable

Panel Discussions/Group Photo

5 Speaker (20 min) slot avilable


Coffee/Tea Break (Networking)



Even

ing Sessions Lunch Break5 Speaker (20 min) slot avilable

Poster Sessions

Even

ing Sessions


NOTE: Program Shedule is subject to change with final allotment of the speaker slotsFor more Details PS: http://optometry.conferenceseries.com

[email protected]| [email protected]

Day 2

Morning

Session

s

Awards & Closing Ceremony

Coffee/Tea Break (Networking)5 Speaker (20 min) slot avilable

30 Spe

akers o

n Day 2



http://nuclearmedicine.conferenceseries.com/e-mail: [email protected]; [email protected]



Conference Highlights• Nuclear Medicine

• Radiation Therapy

• Medical Imaging

• Radiation Physics

• Radiation Oncology

• Diagnostic Radiology

• Interventional Radiology

• Radionuclide

• Imaging Technology

• Ultrasound

• Adjuvant Therapy

• Radiobiology

• Computed Tomography

• Radiopharmacology

• Chemotherapy

• Radiographics

• Magnetic Resonance Imaging

• Nuclear Medicine Equipment

• Side Effects of Nuclear Medicine & Radiation Therapy

• Case Report

For detailed sessions, please visit: http://nuclearmedicine.conferenceseries.com/

Submit your abstract online at: http://nuclearmedicine.conferenceseries.com/abstract-submission.php

Register online: http://nuclearmedicine.conferenceseries.com/registration.php



Glimpses of Nuclear Medicine & Radiation Therapy Conferences



Plan your trip to Edinburgh

Princes Street Gardens

Scott Monument

Holyrood Palace

Royal Botanic Garden Edinburgh

St Giles’ Cathedral


Conference Series-AmericaOne Commerce Center-1201, Orange St. #600, Wilmington, Zip 19899, Delaware, USA

Toll Free: 1-888-843-8169, P: 702-508-5200, F: +1-650-618-1417

Conference Series-UKKemp House, 152 City Road, London EC1V 2NX, UK

Toll Free: +0-800-014-8923

July 17-19, 2017 Lisbon, Portugal

19th Euro Congress on Cancer Science and Therapy

Scientific ProgramJoint Event

25th Cancer Nursing & Nurse Practitioners Conference

&

RegistrationsDay 1 July 17, 2017

Keynote ForumIntroductionTitle: The natural history of breast cancersAlvaro Macieira-Coelho, French National Institute of Health (INSERM), FranceTitle: Hormonal pathology of the endometrium and endometrial neoplasiaLiane Deligdisch, Icahn School of Medicine at Mount Sinai, USA

Networking & Refreshments 10:55-11:10 @ FoyerTitle: Development of an oncology clinical research nursing consulting: A matter of safetyTatiana Massarrah, Gregorio Maranon Hospital, SpainTitle: Breast cancer and personalized medicine: Advances, conundrums and novel therapeutic interventionsSherry A Bradford, AccuTheranostics, Inc., USATitle: Fertility sparing Surgery in Treatment of Early Stage of Cervical CancerAleksandar Stefanovic, Clinical Center of Serbia, Serbia

Group PhotoLunch Break @ Restaurant

Sessions: Organ Defined Cancers | Cancer Genetics | Cancer Biomarkers | Cancer Therapy & Treaments | Cancer Nursing Session Chair: Nyla A Heerema, The Ohio State University Wexner Medical Center, USASession Co-chair: Audrey Claing, Montreal University, Canada

Session IntroductionTitle: CpG simulated karyotypic analysis of chronic lymphocytic leukemia (CLL) is a significant prognostic factor and should be performed on all patientsNyla A Heerema, The Ohio State University Wexner Medical Center, USATitle: Evolution of a system for surgical treatment of adenocarcinomasCharles L Hitchcock, The Ohio State University, USATitle: Creating the best clinical and economic evidence to assist decision-making in urological cancersAlice Dragomir, McGill University, CanadaTitle: Unraveling the full role of P-glycoprotein in multidrug resistant cancersM Helena Vasconcelos, University of Porto, PortugalTitle: ARF proteins as new molecular targets for the treatment of invasive breast cancerAudrey Claing, Montreal University, Canada

Networking & Refreshments @ FoyerVideo Presentation

Title: Efficacy of aloe-vera-gel topical application on radiation-induced-mucositis in head-and-neck-malignancy: A double-blind, randomised clinical trial in Mumbai, IndiaRita Lakhani, Krishna University of Health Sciences, IndiaTitle: An investigation in the role of noncoding RNA’s in epithelial mesenchymal transition (EMT) in prostate cancerHirendra Nath Banerjee, University of North Carolina, USATitle: Challenges of therapeutical options in treatment of early stages of endometrial cancerKatarina Jeremic, University of Belgrade, SerbiaTitle: Do breast cancer units treat patients based on their own neoadjuvant protocols ?Vasco Fonseca, Centro Hospitalar Lisboa Ocidental, Portugal

Panel Discussion

Opening Ceremonyconferenceseries.com

Descobrimentos

Day 2 July 18, 2017Descobrimentos

Keynote ForumIntroductionTitle: Role of the proinflammatory cytokine IL-1b in breast cancer progression to malignancy Isaura Meza, CINVESTAV, MexicoTitle: Why is early psychosocial screening important in pediatric cancer?Maru Barrera, Dept. of Psychology and Division of Hematology/Oncology, Canada

Networking & Refreshments @ FoyerTitle: Preventing chemotherapy-induced onycholysis-A double blind, randomised trial of a polyphenol rich nail bed – The UK polybalm studyRobert Thomas, Bedford and Addenbrooke’s Cambridge University Hospitals, UKSessions: Cancer Therapeutics | Cancer Nursing | Cancer Biology | Cancer Management & Prevention Session Chair: Robert Thomas, Bedford and Addenbrooke’s Cambridge University Hospitals, UKSession Co-chair: Shanmugasundaram Ganapathy Kanniappan, Johns Hopkins University, USA

Session IntroductionTitle: Tumor glycolysis-The stygian link between two hallmarks of cancer and novel therapeutic opportunities Shanmugasundaram Ganapathy Kanniappan, Johns Hopkins University, USATitle: Using ‘zero-ischemia’ and ‘sutureless’ techniques to implement laparoscopic partial nephrectomy with holmium laserQi-Fei Wang, The First Affiliated Hospital of Dalian Medical University, China

Poster Presentation @ Infante HallPoster Judge: Maru Barrera, Dept. of Psychology and Division of Hematology/Oncology, Canada

CS 01Title: Evaluation of early treatment response using dynamic MRI of drug-eluting beads transarterial chemoembolization for hepatocellular carcinomaKuniaki Arai, Kanazawa University Hospital, Japan

CS 02Title: Novel strategy to cure cancerAdnan Yousif Rojeab, London College UCK, UK

CS 03Title: New opportunities for use of novel, small-molecule PERK inhibitors Wioletta Rozpędek, Medical University of Lodz, Poland

CS 04Title: Can P-glycoprotein (P-gp) be involved in the release of larger extracellular vesicles by multidrug resistant cells?M Inês Silva, University of Porto, Portugal

CS 05Title: Is the dissemination of cancer multidrug resistance phenotype influenced by the shedding of extracellular vesicles by resistant tumor cells?Diana Sousa, University of Porto, Portugal

CS 06Title: Investigating the cell growth inhibitory effect of an aqueous extract from Achillea millefolium L. in human tumor cell linesJoana Pereira, University of Porto, Portugal

CS 07Title: SHP inhibits lung cancer progression by coordinating cellular metabolismLiyun Shi, Hangzhou Normal University School of Medicine, China

CS 08Title: Apoptosis induced by Paclitaxel is dependent of BimEL interactome in triple negative breast cancer cellsGina Marcela Méndez-Callejas, University of Applied and Environmental Sciences, Colombia

CS 09Title: Handling of solid health wastes and its risks: Oncology ambulatoryMaria Isabel da G. S. Ramos, University of Cape Verde, Africa

Lunch Break @ Restaurant Title: Novel strategy to cure cancerAdnan Yousif Rojeab, London College UCK, UKTitle: Lifestyle after cancer to reduced toxicity and improved outcomes – What evidence based strategies should we be advising patients? Robert Thomas, Bedford and Addenbrooke’s Cambridge University Hospitals, UKTitle: Communication network mediated by exosomes as a new therapeutic target for pancreatic cancerSonia A Melo, University of Porto, Portugal

Young Researchers ForumTitle: Protein expression profiling of sorafenib-resistant human renal cancer stem-like cells in three-dimensional in vitro modelZofia Felicja Bielecka, Warsaw Medical University, Poland

Networking & Refreshments @ FoyerTitle: Identification and functional evaluation of LRIG1-interacting proteinsMahmood Faraz, Umea University, SwedenTitle: ExoNet-Intratumor communication network mediated by exosomes in pancreatic cancerCarolina F Ruivo, Institute for Research and Innovation in Health, PortugalTitle: Intercellular communication mediated by exosomes as a new therapeutic target forpancreatic cancerNuno Bastos, University of Porto, Portugal

Poster Presentation @ Infante HallPoster Judge: Maru Barrera, Dept. of Psychology and Division of Hematology/Oncology, Canada

CS 10Title: ITM2A, a frequently down-regulation in epithelial ovarian cancer, enhance anti-tumor effects and chemosensitivity of ovarian cancer So Young Kim, Chungbuk National University, South Korea

CS 11Title: Therapeutic effect of double administration of anti-cancer drugs with carboxylesterase-engineered neural stem cells in liver cancerSung S Choi, Chung-Ang University College of Medicine, South Korea

CS 12Title: Influence of a multidisciplinary post-breast cancer rehabilitation program on lifestyle and behavior faced with physical activitiesLeclerc Anne-France, University Hospital Centre of Liege, Belgium

CS 13Title: LRIG1-interacting proteins required for in vitro PDGFRA downregulation functionMahmood Faraz, Umea University, Sweden

CS 14Title: Targeting tumor cells based on phosphodiesterase 3A (PDE3A) expressionMadiha Nazir, Uppsala University, Sweden

CS 15Title: Evaluation of cationic channel TRPV2 as a novel biomarker and therapeutic target in leukemia-implications concerning the resolution of pulmonary dysfunctionFouad Azizi, Hamad Medical Corporation, Qatar

CS 16Title: The network biology of microtubule-targeting agentsAndrés Julián Gutiérrez-Escobar, University of Applied and Environmental Sciences, Colombia

CS 17Title: Blocking WNT5A-interleukin-6-loop as an effective strategy to impair the invasive migration of BRAF-inhibitor (BRAFi) resistant melanoma cellsPurusottam Mohapatra, Lund University, Sweden

CS 18Title: Breast cancer of the young woman: Trends foreseeable with the level of the area of Sidi Bel Abbés, AlgeriaMessafeur Abdelkrim, University Sidi Bel Abbes, Algeria

Panel DiscussionDay 3 July 19, 2017

Extended Networking & Lunch @ RestaurantClosing Ceremony

September 26-28, 2016 London, UK12th World Cancer Conference

Scientific Program


Page 11

RegistrationsConcorde Suite 1&2

Day 1 September 26, 2016

Major Sessions: Cancer | Causes and Prevention | Cancer DiagnosisSession Chair: Alain Charest, Harvard Medical School, USASession Co-Chair: Olivier E Pardo, Imperial College London, UK

Session IntroductionTitle: The tumor supressor INPP4B functions as an oncogenic regulator in a subset of melanomasXu Dong Zhang, University of Newcastle, AustraliaTitle: Plasma thermograms-a new approach for cancer biomarker studiesNichola C Garbett, University of Louisville School of Medicine, USATitle: PDGFRα signaling strength confers sensitivity to vinblastine in glioblastomaAlain Charest, Harvard Medical School, USATitle: p53 protects tumor cell survival via a long non-coding RNA under glucose starvationMian Wu, University of Science & Technology of China, ChinaTitle: NRF2-mediated changes in glutathione metabolism mediate the resistance of EGFR-T790M mutant lung cancer cells to erlotinibOlivier E Pardo, Imperial College London, UK

Panel DiscussionGroup Photo

Lunch Break @ Aromi RestaurantMajor Sessions: Cancer Therapy | Cancer Drugs | Stem Cell ResearchSession Chair: Sabine Mai, University of Manitoba, CanadaSession Co-Chair: Shahid Gilani, University Hospital of North Midlands, UK

Session IntroductionTitle: A 3D imaging platform to determine the level of genomic instability in cancer Sabine Mai, University of Manitoba, Canada Title: Tumor imaging of small animal by phase contrast X-ray CT techniqueThet Thet Lwin, Kitasato University, JapanTitle: Circulating epithelial cells; ready for Routine?! Stefan Schuster, SIMFO GmbH Bayreuth, GermanyTitle: Severe colitis with docetaxel when used in combination with HER-2 receptor blocking antibodies in breast cancer patientsShahid Gilani, University Hospital of North Midlands, UKTitle: Lymhoepithelioma-like carcinoma of the uterine cervix– association with Epstein-Barr virus and Human papillomavirusAngel Danchev Yordanov, UMHAT Doctor Georgi Stranski-Pleven, Bulgaria


Keynote Forum

Introduction

Title: The decline of the prevalence of cancers during organism senescenceAlvaro Macieira-Coelho, French Institute of Health and Medical Research(INSERM), FranceTitle: Early diagnosis of Ovarian carcinoma: Is it possible?Liane Deligdisch, Mount Sinai School of Medicine, USA

Title: Maintrac® CTC detection as a tool to uncover the strategies of tumor cells to evade eliminationKatharina Pachmann, SIMFO GmbH Bayreuth, Germany

Networking and Refreshment Break @ Concorde Foyer

Page 12

Title: A prospective study of dose escalated image guided radiotherapy and concurrent chemotherapy for esophageal cancers: An evolving standard in developing country settingSrinivas Chilukuri, Yashoda Hospitals, India

Networking and Refreshment Break @ Concorde FoyerTitle: Home based carers’ general knowledge of cancer in a rural village of south africaTakalani Grace Tshitangano, University of Venda, South AfricaTitle: Trends in the incidence of oral squamous cell carcinoma: A retrospective studyAmitha J Lewis, Manipal University, India

Panel DiscussionDay 2 September 27, 2016

Concorde Suite 2Keynote Forum

Introduction

Title: The role of stem-like glioma cells in GBM progression and post-treatment recurrenceElla L Kim, Johannes Gutenberg University Medical Centre, GermanyPerineural invasion in pancreatic cancerQingyong Ma, Xi’an Jiaotong University, China

Networking and Refreshment Break @ Concorde FoyerMajor Sessions: Organ Specific Cancers Session Chair: Javier Camacho, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, MexicoSession Co-Chair: Ciro Roberto Rinaldi, University of Lincoln, UK

Session IntroductionTitle: Mechanism of Action of G-quadruplex forming oligonucleotide homologous to the telomere overhang in melanomaNeelu Puri, University of Illinois College of Medicine at Rockford, USATitle: PU.1 Expression correlates with patient disease status in the myelodysplatic syndromes, a new prognostic marker Ciro Roberto Rinaldi, University of Lincoln, UKTitle: The combination astemizole-gefitinib as a novel and promising therapy for human lung cancer: In vitro studiesJavier Camacho, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, MexicoTitle: Near infrared transillumination detection of prostate carcinoma in vitroBesarion Partsvania, Georgian Technical University, GeorgiaTitle: Heightened state of oxidative stress in MCF-7 cells enhances growth potential and promotesEMT by increasing Akt and ERK activityMilad Bitar, Kuwait University, KuwaitTitle: Desmoplasia suppression by Metformin-mediated AMPK activation inhibits pancreatic cancer progressionQingyong Ma, Xi'an Jiaotong University, ChinaTitle: Cytocidal effects of active bufadienolides on human cancer cells and its possibility of enhancing host immunity as an adjuvant therapeutic reagentBo Yuan, Tokyo University of Pharmacy and Life Sciences, Japan

Lunch Break @ Aromi RestaurantYoung Researchers Forum

Title: Diet and colorectal cancer: Black raspberries prolong lifeStephanie May, Cardiff University, UKTitle: BCG-osis following intravesical BCG treatment leading to miliary pulmonary nodules, penile granulomas & a mycotic aortic aneurysmDavid M Smith, St James’ University Hospital, UK Title: H3K4-specific histone methytranferase MLL3 regulates EMT in pancreatic cancer cellsChenyi Liu, University of Toronto, CanadaTitle: Prodigiosin associated anti metastatic effect and induction of apoptosis in adeno gastric carcinomaN Darshan, Central Food Technological Research Institute, IndiaTitle: frequent v600e & other non-hotspot braf mutations in adult differentiated thyroid cancer Murugan Avaniyapuram Kannan, King Faisal Specialist Hospital & Research Center, KSA

Page 13

Title: Association of proline allele at codon 72 of TP53 gene with triple negative breast cancer (TNBC) in females from North Eastern Region, IndiaKaustab Mukherjee, Regional Medical Research Centre-Dibrugarh, ICMR, India Title: Toxin-based targeted therapeutics for the treatment of solid tumorsStefania Zuppone, San Raffaele Scientific Institute, Italy

Networking and Refreshment Break @ Concorde FoyerPoster Presentations 16:10-18:00 @ Concorde Foyer

Day 3 September 28, 2016Meeting Room 9

Major Sessions: Oncology and Cancer | Cancer Treatment and Therapeutics|Alternative Medicine and Cancer | Radiation OncologySession Chair: Jiri Vachtenheim, Charles University in Prague, Czech Republic

Session IntroductionTitle: GLI2, a Hedgehog signaling pathway effector, is a transcription activator of survivin expression in human tumor cellsJiri Vachtenheim, Charles University in Prague, Czech RepublicTitle: psiTPTE22-HERV functions as a tumor suppressor and is epigenetically down-regulated in gastric cancer Jessie Qiaoyi Liang, The Chinese University of Hong Kong, China

Networking and Refreshment Break @ Concorde FoyerTitle: Pathological diagnosis and workup of lung cancer in the middle east and north africa: patterns and challengesMohammed Al Hajjaj, University of Sharjah, UAETitle: Bamboo shoot consumption lowers the risk of breast cancer: A case-control study from North East Region, IndiaK Rekha Devi, Regional Medical Research Centre-Dibrugarh, ICMR, IndiaTitle: Anaemia in cancer patients undergoing radiotherapy: Our experience at the National Hospital Abuja, NigeriaChinedu S Aruah, National Hospital Abuja, NigeriaTitle: The anti-cancer effect of methanolic extract of Pistacia lentiscus MEPL in human ovarian cancer cellsImane Charid, University Abderrahmane Mira, AlgeriaTitle: Prosopis juliflora lleaves extract induces apoptosis in the breast cancer cells Raju N Gacche, Swami Ramanand Teerth Marathwada University, India

Video Presentation Lunch Break @ Aromi Restaurant

Thanks Giving & Closing Ceremony

819th Conferenceconferenceseries.com Scientific Program

14th World Cancer & Anti-CancerTherapy Convention

November 21-23, 2016 Dubai, UAE

Hosting Organizations: Conference Series LLC2360 Corporate Circle., Suite 400 Henderson, NV 89074-7722, USA

Ph: +1-702-508-5200 Ext: 8035, Fax: +1-650-618-1417, Toll free: +1-800-216-6499Conference Series Ltd

Heathrow Stockley Park Lakeside House, 1 Furzeground Way, Heathrow, UB11 1BD, UK, Tel: +1-800-216-6499Email: [email protected] ; [email protected]

Page 15

RegistrationsSalon VI &VII

Day 1 November 21, 2016

Group Photo Networking & Refreshment Break @ Foyer

Special SessionsTitle: Advancing translation of Cancer Biomarkers to Dx applications: The opportunities, challenges and lessons learnedYiu-Lian Fong, Global Diagnostic Innovation Johnson & Johnson Innovation, UKTitle: Management of palatine fistula caused by granulocytic sarcomaRasha Aboelhassan, Nasser Institute Cancer Center, EgyptMajor Sessions: Cancer & Types | Cancer Imaging | Radiation Therapy | Head and Neck CancersBreast Cancer Chair: David Huang, Duke Kunshan University, ChinaChair: Mahmoud Abdelkader, German University, Egypt

Session IntroductionTitle: A new flexible endoscope for Transoral Robot Assisted Surgery (TORS) in head and neck lesionsStephan Lang, University Hospital Essen, GermanyTitle: Whole body MRI in the detection of skeletal metastasis: Our experience with 3 Tesla MRIAbdulkarim Jamal, George Eliot Hospital NHS Trust, UKTitle: Recent advances in radiotherapy treatment techniques David Huang, Duke Kunshan University, ChinaTitle: Diagnosis and management of pericardial mesothelioma Rasha Aboelhassan, Nasser Institute Cancer Center Egypt

Lunch Break @ Market PlaceTitle: Metavert for treating pancreatic cancerMouad Edderkaou, Cedars-Sinai Medical Center, USATitle: Experience and results of 42 patients after 177Lu-octreotate therapy in the Federal Capital of Brazil Gabriela El Haje Lobo, Núcleos Centro de Medicina Nuclear, BrazilTitle: Polyphenols act synergistically with doxorubicin and etoposide in leukaemia cell linesAmani Mahbub, Umm Al Qura University, Saudi ArabiaTitle: Gankyrin: A novel gene that promotes tamoxifen resistance in breast cancer patientsKhadijeh Jamialahmadi, Mashhad University of Medical Sciences, Iran Title: Metastatic papillary serous axillary lymph node from ovarian origin: A case reportMahdiss Mohamadianamiri, Shahid Beheshti University of Medical Sciences, Iran

Demonstration Session By ExibitorTitle: Demonstration on RIGVIR holdingAndrejs Repisevskis, RIGVIR holding, Latvia


Keynote SessionIntroductionTitle: Photodynamic therapy of cancer from bench to clinical application: Overview of 35 years experienceMohamed El-Far, Mansoura University, Egypt

Title: The effects of sustained delivery of Thymoquinone on SW 756 and E6E7 cervical cell lines Hamed Benghuzzi , University of Mississippi Medical Center, USA Title: Epigenetic silencing of promoter genes involved with head and neck carcinomas: Translational research to reverse epigenetic pathways in oncogenesis in head and neck cancer

M.A. Nezami, Pacific Medical Center of Hope, USA

Page 16

Title: Ambulatory chemotherapy fostering empowerment in cancer patients: An introduction and a feasibility study in LebanonRacha Sabbagh Dit Hawasli, Kingston University, UKTitle: Synergistic antitumor effects of radiation and proteasome inhibitor treatment in pancreatic cancer through the induction of autophagy and the down-regulation of TRAF6Ying-Jan Wang, National Cheng Kung University, Taiwan

Networking & Refreshment Break @ FoyerTitle: A propensity matched comparison of effects between video assisted thoracoscopic single-port, two-port and three-port pulmonary resection on lung cancerMu Ju-Wei, National Cancer Center, ChinaTitle: Throat and Lung cancers - Prevention and Management through (Exercise) Expectorant therapiesManikonda Prakash Rao, Osmania University, India

WorkshopTitle: Epigenetic therapies and the use of a Multi-Targeted Approach: A new concept in cancer therapeuticsM.A. Nezami, Pacific Medical Center of Hope, USA

Day 2 November 22, 2016Keynote Session

Title: To boost or not to boost in radiotherapy Bogusław Maciejewski, Cancer Center-Institute, Poland Title: Oncological applications of photodynamic diagnosis and therapyMahmoud Abdelkader, German University, EgyptTitle: Medical physics education and radiation medicineDavid Huang, Duke Kunshan University, China

Networking & Refreshment Break @ FoyerMajor Sessions: Anti- Cancer Therapy | Cancer Imaging | Radiation Therapy | Cancer Screening Session Chair: Nuri Unal, Akdeniz University, TurkeySession Co-Chair: Nina Tuncel, Akdeniz University, Turkey

Session IntroductionTitle: Cancer ImmunotherapySanjay R Jain, Morehouse School of Medicine, USATitle: Particle therapy: Past to futureNuri Unal, Akdeniz University, TurkeyTitle: Optic characteristics of anticancer drug NSC 631570 in urine samples sort healthy donors and prostate adenocarcinoma patients: Can it be exploited for the cancer diagnosticsLarysa M. Skivka, Taras Shevchenko National University, UkraineTitle: Physico-chemical properties of anticancer drug NSC631570Wassil Nowicky, Ukranian Anticancer Institute, AustriaTitle: Time factor and dose fractionation in radiotherapy for head and neck cancerBogusław Maciejewski , Cancer Center-Institute, Poland Title: Adaptive radiotherapy from past to futureNina Tuncel, Akdeniz University, TurkeyTitle: Neuroendocrine tumors treatment by radiolabeled somatostatin analogues (SA).Gabriela El Haje Lobo, Núcleos Centro de Medicina Nuclear, Brazil

Lunch Break @ Market Place

Poster Presentations @ FoyerPoster Presentations @ Foyer

P01Title: Direct medical cost associated with colorectal cancer in North of JordanQais Alefan, Jordan University of Science & Technology, Jordan

P02Title: Polyphenols act synergistically with doxorubicin and etoposide in leukaemia cell linesAmani Mahbub, Umm Al Qura University, Saudi Arabia

P03Title: A dosimetric comparison of the 3D-CRT planning of chest wall in post-mastectomy breast cancer patients, with and without breast board setup.Ambreen Muzaffar, Shifa International Hospital, Pakistan

Page 17

P04Title: Combinative drug therapy for cancer treatment: Exploring synergystic mode of action of Amino and Carboxy Terminal domain Inhibitors of Heat Shock Protein 90( HSP90)Bhaskar Kumar Chatterjee, Indian Institue of Technology, India

P05Title: Study of CYP3A4 and UGT1A1 polymorphisms in chronic myeloid leukemia patients administered nilotinib and relation to hyperbilirubinemiaShaimaa Ahamed Mohamed Ahamed Fahmy, Cairo University, Egypt

P06Title: Second malignant neoplasms after childhood cancer in Korea: A population-based cohort study (1993-2012)Eun-Kyeong Moon, National Cancer Center, South Korea

P07Title: Second primary cancer risk among kidney cancer patients in Korea: A population-based cohort study, 1993-2013 Jiwon Lim, National Cancer Center, South Korea

P08Title: Analysis of the association of apc, mlh1 and rassf1a genes Methylation with the risk of colorectal cancerZhunussova G, Institute of General Genetics and Cytology, Kazakhstan

P09Title: Prolactin pro-differentiation pathway in triple negative Breast Cancer: impact on Prognosis and potential therapyVanessa M. Lopez-Ozuna, McGill University, Canada

P10Title: In Vivo distribution evaluation of combination of lipo-dox and 188re-liposome in breast tumor modelWei-lin Lo, Institute of Nuclear Energy Research, Taiwan

P11Title: A new therapeutic targets of multiple myelomaDongqing Zhang, Shanghai jiao tong university, China

P12Title: OVA66 increases ovarian cancer cell growth, invasion and survival via regulation of IGF-1R-MAPK signalingLi Wang, Shanghai Jiaotong University, China

P13Title: OVA66 increases ovarian cancer cell growth, invasion and survival via regulation of IGF-1R-MAPK signalingYebin Xi, Shanghai Jiaotong University, China

P14Title: OVA66 increases ovarian cancer cell growth, invasion and survival via regulation of IGF-1R-MAPK signalingHailiang Ge, Shanghai Jiaotong University, China

P15Title: Efficacy of lithospermi radix water extracts for the attenuation of oxaliplatin-induced neurotoxicity. Jin-Mu Yi, Korea Institute of Oriental Medicine (KIOM), Republic of Korea

P16Title: KIOM-CRC 140(FFWE) attenuates oxaliplatin-induced neurotoxicity in vitro and vivo model.Jin-Mu Yi, Korea Institute of Oriental Medicine (KIOM), Republic of Korea

P17Title: Novel small molecule inhibitor of KPNB1 induce apoptosis and interfere with nuclear import in cancer cellsAderonke Ajayi-Smith, University of Cape Town Health Sciences Faculty, South Africa

P18Title: Synthesis, In Vitro antiproliferative activity and kinase inhibitory effects of new quinoline derivativesMohammed El-Gamal, University of Mansoura, Mansoura, Egypt.

P19Title: Intratumor stromal proportion confers aggressive phenotype of gastric signet ring cell carcinomasDakeun Lee, Ajou University, South Korea

P20Title: miR-96 promotes the growth of prostate carcinoma cells by suppressing MTSS1Ling Zhang, Jilin University, China

Page 18

P21Title: Novel graphene oxide particles as a Plasmid-based Stat3 siRNA carrier for mouse hepatocarcinoma targeted therapyBaofeng Guo, Jilin University, China

P22Title: Prolactin receptor expression is an independent favorable prognostic marker in human breast cancerIbrahim Yaseen Hachim, McGill University, Canada

P23Title: The prognostic value of apoptotic marker (CD95) in adult acute leukemias Abdulwahab Abuderman, Salman bin Abdulaziz University, KSA

P24Title: mTOR pathway proteins expression after treatment of head and neck cancer cell lines with mTOR inhibitorsGabriel A Borges, University of Brasilia, Brazil

P25Title: A comprehensive analysis of malignancies diagnosed and treated in Andaman & Nicobar Island in one yearP P Abdul Shahid, Andaman and Nicobar Island, India

Special SessionTitle: Oncolytic virotherapy with Rigvir® Simona Donina, Riga Eastern Clinical University, LatviaMajor Sessions: Targeted Anti- Cancer Therapy | Cancer Biomarkers | Medical Image Processing Chair: Madhulika Singh, CSIR-Indian Institute of Toxicology Research, IndiCo- Chair: Ambreen Muzaffar, Shifa International Hospital, Pakistan

Title: Differential miRNAs expression profiles classify Mucin 1(+)/(-) human breast cancer stem cellsMadhulika Singh, CSIR-Indian Institute of Toxicology Research, IndiaTitle: Effects of histone deacetylase inhibitors on anti neo plastic activityJuhi Tiwari, Jayoti Vidyapeeth Women’s University, IndiaTitle: Investigating preoperative hematologic markers for the prognosis of ovarian cancer surgical outcomeMahdiss Mohamadianamiri, Shahid Beheshti University of Medical Sciences, Iran.

Networking & Refreshment Break @ FoyerTitle: A dosimetric comparison of the 3D-CRT planning of chest wall in post-mastectomy breast cancer patients, with and without breast board setupAmbreen Muzaffar, Shifa International Hospital, PakistanTitle: Identifying the intra-tumoral heterogeneity of GBM using diffusion tensor image segmentation technique: A look inside application in prediction of overall survival Manijeh Beigi, Tehran University of Medical Sciences, IranTitle: Pyrexia of unknown originShrikant Solav, Spect Lab Nuclear Medicine Services, IndiaTitle: Up-regulation of the androgen receptor co-repressor; prohibitin, leads to cell cycle arrest in an androgen dependent prostate cancer cell line; LNCaPs. Sarah Koushyar, Cardiff University, UKTitle: Innovative approaches in metabolomics for understanding drug resistance in breast cancer Umber Saeed, Dow University of Health & Sciences (DUHS), Pakistan

Day 3 November 23, 2016Special Session

Title: Origins of life and role of quantum mechanics and thermodynamics approach in cancer Marek Roland, Digital Recordings, CanadaTitle: Biological interventions to interfere microenvironmental and endocrine machinery in cancer SubTitle: Application of endocrine manipulation in advanced cancerMA Nezami, Pacific Medical Center of Hope, USA

Networking & Refreshment Break @ Foyer

WorkshopTitle: Sequential targeted therapy in Cancer Applications and methods of treating actionable targets in multiphase approachMA Nezami, President Pacific Medical Center of Hope, USA

Page 19

Major Sessions: Cancer Cell Biology| Cancer Therapy| Cancer Biomarker | Hematology-oncology Chair: Wassil Nowicky, Ukranian Anticancer Institute, AustriaCo- Chair: Ying-Jan Wang, National Cheng Kung University, Taiwan

Session IntroductionTitle: Magnetic properties and antitumor effect of nanocomplexes of iron oxide and doxorubicinThanos Mitrelias, University of Cambridge, UKTitle: Unusual presentations of posttransplant lymphoproliferative disorder in pediatric recipients of solid organ transplants: A systematic reviewNader Shakibazad, Shiraz University of Medical Sciences, IranTitle: Acute abdomen as an unusual presentation of acute myeloid leukemia: A case reportMehrpour Moradi, Shiraz University of Medical Sciences, IranTitle: D2 Gastrectomy: A single institution experienceAhmed Mohamed Osama Touny, Cairo University, Egypt Title: Psychosocial health status of patients diagnosed with chronic illnesses in Jordan. Dana Al Abeiat, SKSH, Shaikh khalifa Specialty Hospital, UAETitle: IGF-II and NSC-631570 compounds affect PMP22 gene expression in Pancreatic Ductal Adenocarcinoma. Could be the new target for both chemo-resistance and neuronal invasionNiccola Funel, University of Pisa, Italy

Lunch Break @ Market PlaceTitle: Evaluation of the anticancer activities of the plant alkaloids Sanguinarine and Chelerythrine in human breast adenocarcinoma cellsIgor Vivian Almeida, State University of Maringa, Brazil Title: Vinca alkaloids induced peripheral neuropathy: Case series Shahbaz Ahmad Khan , Shaukat khanum Cancer hospital, Pakistan Title: In-vitro antioxidant and superoxide anion radical scavenging activity of pollen of Centella asiatica (Linn) Urban a traditional medicinal plant from Punjab-PakistanAnjum Perveen, University of Karachi, Pakistan

Networking & Refreshment Break @ Foyer

Closing & Award Ceremony

Documents

3 Nuclear Medicine & Radiation Therapy · • Nuclear Medicine • Radiation Therapy • Medical Imaging • Radiation Physics • Radiation Oncology • Diagnostic Radiology •